Request Sample

Global Next Generation Sequencing (NGS) Market

March 26, 2018

Global Next Generation Sequencing (NGS) Market, By Product Type (Consumables, Platforms, Sequencing Services (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine and Genetic Screening, Agricultural & Animal Research, Other Applications), By End User (Academic Institutes & Research Centers, Hospitals, Pharmaceutical & Biotechnology Companies, Others), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR354      
Pages :296 Pages
Format :   PPT Format   PDF Format

The global next generation sequencing (NGS) market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020 and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). NGS is used to analyze the structural and functional genomic with the help of generated data. The adoption of NGS is increasing worldwide as it provides various parallel analysis, extremely high-throughput from several samples of blood, plant cells, and tissues in a cost-effective method. This acts as driving factor for growth of the market.

Table 1. Global Next generation Sequencing (NGS) Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Product Type)

Consumables, Platforms, Sequencing Services (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, Others)

Market Segmentation (By Application)

Diagnostics, Drug Discovery, Personalized Medicine and Genetic Screening,

Agricultural & Animal Research, Other Applications

Market Segmentation (By End User)

Academic Institutes & Research Centers, Hospitals, Pharmaceutical & Biotechnology Companies, Others

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

Illumina, Inc., Thermo Fisher Scientific, Inc., BGI Group, Perkinelmer, Agilent Technologies, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Genewiz, Eurofins Scientific, Genomatix GmbH, PierianDx, and Psomagen, Inc. among others.

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

Low costs, and technological advancement in the platforms has created the demand for the NGS in the healthcare industry. The cost of per genome has decreased from US$ 100 million in 2001 to US$ 10,000 in 2014. Further, rise in the initiatives by various academic and research centers to do in-depth R&D for NGS technology is also expected to propel the market growth in the foreseen future. However, complexity of the collected data poses challenge to the growth of the market which requires skilled employee and exhaustive process of analysis of the collected data to gain the insights.

Figure 1. PORTER’S Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is expected to hold dominant position in the next generation sequencing (NGS) market followed by Europe, attributed to increased R&D and support from the government via funding and favorable regulations. For instance, in 2015, National Institutes of Health (NIH) granted US$ 21 billion for research in the U.S. The expanding application base for NGS has also boosted its adoption in the majority of the regions. The companies such as Eurofins and bioMérieux have made significant development in the field of NGS by adopting strategies such as acquisition and partnership. This enables the future growth of the NGS in these regions.

Figure 2. Regional Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players in the global next generation sequencing (NGS) market includes: Illumina, Inc., Thermo Fisher Scientific, Inc., BGI Group, Perkinelmer, Agilent Technologies, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Genewiz, Eurofins Scientific, Genomatix GmbH, PierianDx, and Psomagen, Inc. among others.

The companies have adopted various organic as well as inorganic growth strategies such as expansion, acquisition, partnership, and product launches for strengthening their position in the market. For instance, in February 2019, Agilent introduced a new fully automated Magnis next-generation sequencing library preparation system that enable to run complex DNA sequencing assays with one-day turnaround time.

Figure 3. Market Share of Key Players, 2019

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Product Type

  • Consumables
  • Platforms
  • Sequencing Services
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • RNA Sequencing
    • Targeted Re-sequencing
    • Others

By Application

  • Diagnostics
  • Drug Discovery
  • Personalized Medicine and Genetic Screening   
  • Agricultural & Animal Research
  • Other Applications

By End User

  • Academic Institutes & Research Centers
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global next generation sequencing (NGS) market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by the key players in the global next generation sequencing (NGS) market?
  • What key factors are expected to increase the demand for next generation sequencing (NGS) market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global next generation sequencing (NGS) market?
  • What is the total market value (US$ Mn) generated in global next generation sequencing (NGS) market by product type in 2019 and what are the forecasts by 2025?
  • Which application (diagnostics; drug discovery; personalized medicine and genetic screening; agricultural & animal research; and other applications) is expected to dominate the next generation sequencing (NGS) market in the coming years?
  • Which product type of next-generation sequencing (NGS) is expected to propel the market in the foreseen future?
  • What was the total revenue generated by the global next-generation sequencing (NGS) market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global next-generation sequencing (NGS) market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the next-generation sequencing (NGS) market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.